ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis (ENDOMET)
Novel Diagnostic Tools for Endometriosis and Their Exploitation for Prognosis and Prevention of Complications
Sponsor: Biotop Oy
Listed as NCT01301885, this observational or N/A phase trial focuses on Endometriosis and remains actively recruiting participants. Sponsored by Biotop Oy, it has been updated 11 times since 2005, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2021 — Jul 2024 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Oct 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biotop Oy
- Drug Discovery Graduate School, Finland
- Finnish Medical Foundation
- Hormos Medical
- PerkinElmer, Wallac Oy
- Pharmatest Services Ltd
- The Finnish Funding Agency for Technology and Innovation (TEKES)
- The National Graduate School of Clinical Investigation, Finland
- Turku University Hospital
- University of Turku
- VTT Technical Research Centre of Finland
For direct contact, visit the study record on ClinicalTrials.gov .